Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC.
Mol Cancer Res
; 15(3): 304-316, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-28031408
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Osteonectin
/
Receptor, ErbB-2
/
Mammary Neoplasms, Experimental
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Cancer Res
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: